Objectives: At the end of this program, participants should be able to:

1. To introduce ex-RNAs as a new class of biomarkers for stroke

2.  To demonstrate how next-generation sequencing technology can be cobined with clinical samples to provide new insight about complex disease.


Session date: 
11/28/2018 - 8:30am to 9:30am CST
UCMC J-320
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
M. Yashar Kalani, M.D., PhD.